We have made the unprecedented decision to temporarily suspend upcoming routine outpatient appointments in response to the extraordinary COVID-19 (Coronavirus) situation.
We have a wealth of expertise in rare disorders and many of our clinicians are internationally recognised specialists who provide an unrivalled standard of care for our patients.
Please click on the below link for general advice regarding Coronavirus (COVID-19) for patients with rare genetic disorders.
As part of the 100,000 genomes project, the GMC aims to integrate the latest genomic technologies across the entire NHS, for cancer and rare diseases.
By integrating clinical care with ground breaking research, we use cutting edge technologies to improve diagnosis, direct effective management, and work towards developing novel treatments for patients with rare diseases and with a family history of cancer.
MCGM has a broad experience of delivering training for clinical scientists, genetic counsellors and clinicians, and research scientists.
MCGM is a leading centre for clinical genomics. Using the most advanced technologies, we make personalised medicine a reality for our patients and families.
Specialist centre for genetic metabolic disorders in children
We are one of 13 designated GMCs delivering the 100,000 genome project
Patients are at the centre of service development, research and education. Get involved with our patient advisory group.
Information about referrals, referral guidelines and service specifications
Search for laboratory services and specific tests
Find our laboratory request card for blood samples and other useful referral forms